Oxidative Stress (Malondialdehyde) in Adults Beta-Thalassemia Major and Intermedia: Comparison Between Before and After Blood Transfusion and Its Correlation with Iron Overload

References

• Gunarsih A, Amalia P, Boediman I. Variables associated with malondialdehyde level in patients with thalassemia major. Paediatr Indones. 2012;52:125–131. doi:10.14238/pi52.3.2012.125-31
   Google Scholar
• Cappellini MD, Cohen A, Porter J, et al. Guidelines for the Management of Transfusion-Dependent Thalassemia. Thalassemia International Federation; 2014.
   Google Scholar
• Gamberini MR, De Sanctis V, Gilli G. Hypogonadism, diabetes mellitus, hypothyroidism, hypoparathyroidism: incidence and prevalence related to iron overload and chelation therapy in patients with thalassaemia major followed from 1980 to 2007 in the Ferrara Centre. Pediatr Endocrinol Rev. 2008;6(Suppl 1):158–169.
   PubMedGoogle Scholar
• Thalassemia Center Cipto Mangunkusumo Hospital. Thalassemia major patients data. Jakarta; 2016. [unpublished document].
   Google Scholar
• Wood B, Molecular Higgs D. Basis of thalassemia syndromes. Disorders of erythropoiesis, erythrocytes and iron metabolism. Eur Sch Hematol. 2009;35:406
   Google Scholar
• Taher AT, Vichinsky E, Musallam Ea K. Guidelines for the Management of Non-Transfusion Dependent Thalassemia (NTDT). Thalassemia International Federation; 2013.
   Google Scholar
• Kohgo Y, Ikuta K, Ohtake T, et al. Body iron metabolism and pathophysiology of iron overload. Int J Hematol. 2008;88(1):7–15. doi:10.1007/s12185-008-0120-5
   PubMed Web of Science ®Google Scholar
• Hershko C. Pathogenesis and management of iron toxicity in thalassemia. Ann N Y Acad Sci. 2010;1202:1–9. doi:10.1111/j.1749-6632.2010.05544.x
   PubMed Web of Science ®Google Scholar
• Kalpravidh RW, Siritanaratkul N, Insain P, et al. Improvement in oxidative stress and antioxidant parameters in beta-thalassemia/Hb E patients treated with curcuminoids. Clin Biochem. 2010;43(4–5):424–429. doi:10.1016/j.clinbiochem.2009.10.057
   PubMed Web of Science ®Google Scholar
• Nielsen F, Mikkelsen BB, Nielsen JB, et al. Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style factors. Clin Chem. 1997;43(7):1209–1214. doi:10.1093/clinchem/43.7.1209
   PubMed Web of Science ®Google Scholar
• Sengsuk C, Tangvarasittichai O, Chantanaskulwong P, et al. Association of iron overload with oxidative stress, hepatic damage and dyslipidemia in transfusion-dependent β-Thalassemia/HbE patients. Indian J Clin Biochem. 2014;29(3):298–305. doi:10.1007/s12291-013-0376-2
   PubMedGoogle Scholar
• Naithani R, Chandra J, Bhattacharjee J, et al. Peroxidative stress and antioxidant enzymes in children with beta-thalassemia major. Pediatr Blood Cancer. 2006;46(7):780–785. doi:10.1002/pbc.20669
   PubMed Web of Science ®Google Scholar
• Al-Hakeim HK, Auda FM, Ali BM. Lack of correlation between non-labile iron parameters, total carbonyl and malondialdehyde in major thalassemia. J Clin Biochem Nutr. 2014;55(3):203–206. doi:10.3164/jcbn.14-24
   PubMed Web of Science ®Google Scholar
• Cighetti G, Duca L, Bortone L, et al. Oxidative status and malondialdehyde in beta-thalassaemia patients. Eur J Clin Invest. 2002;32(Suppl 1):55–60. doi:10.1046/j.1365-2362.2002.0320s1055.x
   PubMed Web of Science ®Google Scholar
• Walter PB, Macklin EA, Porter J, et al. Inflammation and oxidant-stress in beta-thalassemia patients treated with iron chelators deferasirox (ICL670) or deferoxamine: an ancillary study of the Novartis CICL670A0107 trial. Haematologica. 2008;93(6):817–825. doi:10.3324/haematol.11755
   PubMed Web of Science ®Google Scholar
• Boudrahem-Addour N, Izem-Meziane M, Bouguerra K, et al. Oxidative status and plasma lipid profile in β-Thalassemia patients. Hemoglobin. 2015;39(1):36–41. doi:10.3109/03630269.2014.979997
   PubMed Web of Science ®Google Scholar
• Abduljabbar A, Mehmetçik G. Malondialdehyde and C-Reactive protein values in transfusion dependent thalassemia patients; 2018.
   Google Scholar
• Ozturk Z, Genc GE, Kupesiz A, et al. Thalassemia major patients using iron chelators showed a reduced plasma thioredoxin level and reduced thioredoxin reductase activity, despite elevated oxidative stress. Free Radic Res. 2015;49(3):309–316. doi:10.3109/10715762.2015.1004327
   PubMed Web of Science ®Google Scholar
• Yanpanitch OU, Hatairaktham S, Charoensakdi R, et al. Treatment of β-Thalassemia/Hemoglobin E with antioxidant cocktails results in decreased oxidative stress, increased hemoglobin concentration, and improvement of the hypercoagulable state. Oxid Med Cell Longev. 2015;2015:537954. doi:10.1155/2015/537954
   PubMed Web of Science ®Google Scholar
• Tesoriere L, D’Arpa D, Maggio A, et al. Oxidation resistance of LDL is correlated with vitamin E status in beta-thalassemia intermedia. Atherosclerosis. 1998;137(2):429–435. doi:10.1016/s0021-9150(97)00300-6
   PubMed Web of Science ®Google Scholar
• Nasseri E, Mohammadi E, Tamaddoni A, et al. Benefits of curcumin supplementation on antioxidant status in β-thalassemia major patients: a double-blind randomized controlled clinical trial. Ann Nutr Metab. 2017;71(3–4):136–144. doi:10.1159/000479634
   PubMed Web of Science ®Google Scholar
• Maurya RP, Prajapat MK, Singh VP, et al. Serum malondialdehyde as a biomarker of oxidative stress in patients with primary ocular carcinoma: impact on response to chemotherapy. Clin Ophthalmol. 2021;15:871–879. doi:10.2147/OPTH.S287747
   PubMed Web of Science ®Google Scholar
• Ezzat AM, Abdelmotaleb GS, Shaheen AM, et al. Peroxidative stress and antioxidant enzymes in children with beta-thalassemia major. Med Res J. 2016;15(2):57–62. doi:10.1097/01.MJX.0000511315.53248.78
   Google Scholar
• El-Shanshory M, Hablas NM, Shebl Y, et al. Al-hijamah (wet cupping therapy of prophetic medicine) significantly and safely reduces iron overload and oxidative stress in thalassemic children: a novel pilot study. J Blood Med. 2018;9:241–251. doi:10.2147/JBM.S170523
   PubMed Web of Science ®Google Scholar
• Almaiman AA. Proteomic effects of wet cupping (Al-hijamah). Saudi Med J. 2018;39(1):10–16. doi:10.15537/smj.2018.1.21212
   PubMed Web of Science ®Google Scholar
• Ondei L, Estevão I, Rocha MIP, et al. Oxidative stress and antioxidant status in beta-thalassemia heterozygotes. Rev Bras Hematol Hemoter. 2013;35(6):409–413. doi:10.5581/1516-8484.20130122
   PubMedGoogle Scholar
• Rasool M, Malik A, Jabbar U, et al. Effect of iron overload on renal functions and oxidative stress in beta thalassemia patients. Saudi Med J. 2016;37(11):1239–1242. doi:10.15537/smj.2016.11.16242
   PubMed Web of Science ®Google Scholar